Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?
NCT ID: NCT02509351
Last Updated: 2016-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
280 participants
INTERVENTIONAL
2015-10-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The aim of the this study is to address if there is any benefits 'regarding the intra-operative blood loss' from preoperative rectal administration of 400 mic of Misoprostol in addition to the routinely administrated 10 units of oxytocin
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In women undergoing elective ceserean section, is preoperative 400 mic Misoprostol reduce intra-operative blood loss?
Research hypothesis:
pre-operative Misoprostol doesn't reduce intraoperative blood loss in women undergoing ceserean section
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
misoprostol
women receiving pre-operative rectally administered 400 microgram misoprostol
misoprostol
400 microgram of misoprostol is given preoperatively in patients undergoing elective cesarean section
placeboo
women receiving placebo
placeboo
women will recive 2 identical tablets as placeboo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
misoprostol
400 microgram of misoprostol is given preoperatively in patients undergoing elective cesarean section
placeboo
women will recive 2 identical tablets as placeboo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for elective lower segment cesarean section
Exclusion Criteria
* more than previous 2 ceserean sections
* multiple pregnancy
* antepartum haemorrhage
* self-reported maternal heart disease
* current diagnosis of severe malaria or acute bacterial infection
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed El Kotb Abdel Fattah
doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helmy Dr metawe, MD
Role: STUDY_CHAIR
Ain Shams University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Ain Shams University
Cairo, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POMCS
Identifier Type: -
Identifier Source: org_study_id